Advertisement
Canada markets close in 1 hour 1 minute
  • S&P/TSX

    21,865.79
    -10.00 (-0.05%)
     
  • S&P 500

    5,497.41
    +22.32 (+0.41%)
     
  • DOW

    39,267.32
    +97.80 (+0.25%)
     
  • CAD/USD

    0.7312
    +0.0029 (+0.40%)
     
  • CRUDE OIL

    82.91
    -0.47 (-0.56%)
     
  • Bitcoin CAD

    85,166.57
    -1,813.09 (-2.08%)
     
  • CMC Crypto 200

    1,315.53
    -28.97 (-2.15%)
     
  • GOLD FUTURES

    2,335.90
    -3.00 (-0.13%)
     
  • RUSSELL 2000

    2,032.89
    +2.82 (+0.14%)
     
  • 10-Yr Bond

    4.4420
    -0.0370 (-0.83%)
     
  • NASDAQ

    18,002.97
    +123.67 (+0.69%)
     
  • VOLATILITY

    11.89
    -0.33 (-2.70%)
     
  • FTSE

    8,121.20
    -45.56 (-0.56%)
     
  • NIKKEI 225

    40,074.69
    +443.63 (+1.12%)
     
  • CAD/EUR

    0.6805
    +0.0028 (+0.41%)
     

One CVS Health Corporation (NYSE:CVS) insider reduced their stake by 2.6% in the previous year

Looking at CVS Health Corporation's (NYSE:CVS ) insider transactions over the last year, we can see that insiders were net sellers. That is, there were more number of shares sold by insiders than there were purchased.

While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.

View our latest analysis for CVS Health

CVS Health Insider Transactions Over The Last Year

Over the last year, we can see that the biggest insider sale was by the insider, Prem Shah, for US$180k worth of shares, at about US$107 per share. That means that an insider was selling shares at around the current price of US$98.16. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. We note that this sale took place at around the current price, so it isn't a major concern, though it's hardly a good sign. The only individual insider seller over the last year was Prem Shah.

ADVERTISEMENT

You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
insider-trading-volume

For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Insider Ownership Of CVS Health

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. I reckon it's a good sign if insiders own a significant number of shares in the company. CVS Health insiders own 0.2% of the company, currently worth about US$309m based on the recent share price. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

So What Do The CVS Health Insider Transactions Indicate?

There haven't been any insider transactions in the last three months -- that doesn't mean much. It's heartening that insiders own plenty of stock, but we'd like to see more insider buying, since the last year of CVS Health insider transactions don't fill us with confidence. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. In terms of investment risks, we've identified 1 warning sign with CVS Health and understanding this should be part of your investment process.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here